Clinical Trial of Tripterygium Wilfordii Hook F. in Human Kidney Transplantation in China

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1274-1279

  Ji, S M ^a   Wang, Q W ^a   Chen, J S ^a   Sha, G Z ^a   Liu, Z H ^b   Li, L S ^b  

^a JINLING HOSPITAL   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHINESE DRUG; CYCLOSPORIN A; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; TRIPTERYGIUM WILFORDII HOOK F; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; CANCER; CAUSE OF DEATH; CD25+ T LYMPHOCYTE; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT SURVIVAL; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LIVER DYSFUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; BIOPSY; CHIN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEDICINE, HERBAL; PHYTOTHERAPY; PLANT EXTRACTS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRIPTERYGIUM;

EID: 33745223816     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.017     Document Type: Article

References (32)

1. Womer K.L., Vella J.P., and Sayegh M.H. Chronic allograft dysfunction. mechanisms and new approaches to therapy. Sem Nephrol 202 (2000) 126
2. Dickenmann M.J., Nickeleit V., Tsinalis D., et al. Why do kidney grafts fail? A long-term single-center experience. Transpl Int 15 (2002) 508
3. Sijpens Y.W.J., Doxiadis I.I.N., Mallat M.J.K., et al. Early versus late acute rejection episodes in renal transplantation. Transplantation 75 (2003) 204
4. Shu-ming J., Hui-ping C., Qing-Wen W., et al. Clinical and pathological research of acute vascular rejection in kidney transplantation. J Nephrol Dial Transplant 7 (1998) 25
5. Sells R.A. Iatrogenic problems caused by immunosuppressive drugs in transplant recipients. Transplant Proc 30 suppl 8A (1998) 14s
6. Tao X., Sun Y., Dong Y., et al. A prospective, controlled, double-blind, cross-over study of Tripterygium Wilfordii Hook F in the treatment of rheumatoid arthritis. Chin Med J Engl 102 (1989) 327
7. Gu W.Z., and Brandwein S.R. Inhibition of type II collagen induced arthritis in rats by triptolide. Int J Immunopharmacol 20 (1998) 389
8. Wei-xin H., Zheng T., Xiao-dan Y., et al. Double dosage of Tripterygium Wilfordii Hook F in treating nephritic syndrome. A prospective clinical trial. J Nephrol Dialy Transplant 6 (1997) 210
9. Qin W.Z., Liu C.H., and Yang S.M. Tripterygium Wilfordii Hook F in systemic lupus erythematosus. Chin Med J 94 (1981) 827
10. Zhang X.Y., Tsuchiya N., Dohi M., et al. Prolonged survival of MRL-lpr/lpr mice treated with Tripterygium Wilfordii Hook F. Clin Immunol Immunopath 62 (1992) 66
11. Liao C.X., Li J.S., et al. Low dose cyclosporin A and Tripterygium Wilfordii inhibited porcine intestinal allograft rejection. Chin Med J Engl 107 (1994) 669
12. Zhang L.X., Xu W.M., Cao Z.F., et al. Inhibitory effect of tripterine on lymphocyte proliferation in mice. Acta Pharmacol 7 (1986) 85
13. Shu-ming J., Guang Y., Qing-wen W., et al. Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation. J Nephrol Dialy Transplant 7 (1998) 415
14. Lei-shi L. Tripterygium Wilfordii. A new lead in treating glomerular disease and preventing allograft rejection. Chinese J Dial Artif Organs 8 (1997) 31
15. Gu W.Z., Chen R., Brandwein S., et al. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium. triptolide and tripdiolide. Int J Immunopharm 17 (1995) 351
16. Zheng J.R., Fang J.L., and Gu K.X. Screening of active anti-inflammatory immunosuppressive and antifertile compositions from Tripterygium Wilfordii. I. Screening of 8 components from total glycosides of Tripterygium Wilfordii (T II). Acta Acad Med Sinicae 9 (1987) 317
17. Tao X., Cai J.J., Lipsky P.E., et al. The identity of immunosuppressive components of the ethyl acetate extracts and chloroform methanol extract T 2 of Tripterygium Wilfordii Hook F. J Pharmacol Exp Ther 272 (1995) 1305
18. Fan Y.Y., and Chen S.X. Immunological effects of Tripterygium wilfordii Hook F. Chin J Exp Clin Immunol 2 (1990) 40
19. Lee K.Y., Chang W.-T., Qiu D., et al. PG490 (Triptolide) cooperates with tumor necrosis factor-α to induce poptosis in tumor cells. J Biol Chem 274 (1999) 13451
20. Yang Y., Liu Z.-H., Tolosa E., et al. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 40 (1998) 139
21. Hong Y., Zhou W., Li K., et al. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 62 (2002) 1291
22. Yang S.X., Xie S.S., Hu G.K., et al. Inhibitory effect of triptolide on IL-2 receptor expression of human tonsil lymphocytes. Chinese J Immunol 9 (1993) 189
23. Yang Y., Liu Z., Tolosa E., et al. Triptolide induces apoptotic death of T lymphocytes. Immunopharmacology 40 (1998) 139
24. Qiu D., Zhao G., Aoki Y., et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappa B transcriptional activation. J Biol Chem 274 (1999) 13443
25. Krishna G., Liu K., Shigemitsu H., et al. PG490-88, a derivative of triptolide, blocks belomycin-induced lung fibrosis. Am J Pathol 158 (2001) 997
26. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713
27. Shu-ming J.I., Lei-shi L., Da-xi J., et al. Impact of acute rejection on chronic rejection in kidney transplantation. Chinese J Dial Artif Organs 6 (1995) 18
28. Gulanikar A.C., MacDonald A.S., Sungertekin U., et al. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 53 (1992) 323
29. Yang S.X., Xie S.S., Gao H.L., et al. Triptolide suppresses T lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. Int J Immunopharmacol 16 (1994) 895
30. Zhang L.X., Xu W.M., Cao Z.F., et al. Inhibitory effect of tripterine on lymphocyte proliferation in mice. Acta Pharmacol 7 (1986) 85
31. Jun-wei Y., Chao-hong C., Dong L., et al. Triptolide induces growth arrest of human T cells through its apoptotic effect. J Nephrol Dialy Transplant 6 (1997) 214
32. Wang J., Xu R., Jin R., et al. Immunosuppressive activity of the Chinese medicinal plant Tripterygium Wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 70 (2000) 447